Taiyou Leopoldo Harada1, Kazuhiro Saito1, Yoichi Araki1, Jun Matsubayashi2, Toshitaka Nagao2, and Koichi Tokuuye1
1Radiology, Tokyo Medical University Hospital, Shinjuku-ku, Japan, 2Pathology, Tokyo Medical University Hospital, Shinjuku-ku, Japan
This study is to evaluate which is favorable surrogate
marker to predict the liver fibrosis, DWI or quantitative enhancement ratio
measured at hepatobiliary phase on Gd-EOB-DTPA enhanced-MRI. Eighty-three
patients with 99 lesions were enrolled. ADC was measured at a distance of 5-10
mm from the tumor. Liver-to-muscle ratio (LMR), liver-to-spleen ratio (LSR) and
contrast enhancement index (CEI) were calculated. ADC showed no significant difference
among fibrosis grades. LMR and CEI showed significant differences between high
stage and low stage fibrosis group (p<0.01 and p=0.04). In conclusion, LMR
was best surrogate parameters to distinguish high stage from low stage
fibrosis.